My Account

Thursday, December 26, 2024

Canada’s Politics and Government News Source Since 1989

Pharmacare report shows government favours ‘incremental,’ ‘middle-course’ approach to reform: observers

A spokesperson for the health minister says it’s ‘too soon’ to speculate on potential approaches, as the pharmacare advisory council will submit its final report by June.

News
BY SAMANTHA WRIGHT ALLEN
March 13, 2019

News | BY SAMANTHA WRIGHT ALLEN | March 13, 2019

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More News

AFN national chief urges politicians to ‘put their politics aside’ to support First Nations’ access to clean water

NewsBY IREM KOCA

House, Senate get green light for 2025-26 spending asks

NewsBY LAURA RYCKEWAERT

Expanding AI in government operations, modernizing Service Canada sites among feds’ fiscal update’s public service-related measures

NewsBY SOPHALL DUCH

Prime Minister’s Office confirms it cancelled year-end media interviews following fallout from Freeland’s bombshell mic drop

NewsBY SOPHALL DUCH

Trudeau’s cabinet shuffle fails to quiet doubts about his future

NewsBY IAN CAMPBELL

Trudeau promotes eight Liberal MPs, moves ministers in long-awaited cabinet shuffle

NewsBY SAMANTHA WRIGHT ALLEN, IAN CAMPBELL, SOPHALL DUCH, STUART BENSON | UPDATED December 20, 2024

Prime Minister Justin Trudeau attempted to revive his embattled government on Dec. 20 with a cabinet major shake-up.

Trudeau promotes eight Liberal MPs, moves ministers in long-awaited cabinet shuffle

NewsBY SAMANTHA WRIGHT ALLEN, IAN CAMPBELL, SOPHALL DUCH, STUART BENSON | UPDATED December 20, 2024

Prime Minister Justin Trudeau attempted to revive his embattled government on Dec. 20 with a cabinet major shake-up.

Senate standoff sees Conservatives wield ‘exceptional and rarely used’ motion, putting two private members’ bills on ice

House approves new funds, office handover rules ahead of next election

Miller, Anand, MacKinnon expected to get new portfolios in Friday cabinet shuffle: Liberal source

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

A prescription for equity: ensuring young Canadians’ health through National Pharmacare

OpinionBY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED

The wait for pharmacare has gone on long enough

OpinionBY JOEL LEXCHIN

Pharmacare in Canada: one step forward, two steps back

OpinionBY MARC-ANDRé GAGNON

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

NewsBY JESSE CNOCKAERT

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

A prescription for equity: ensuring young Canadians’ health through National Pharmacare

OpinionBY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED

A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to choose jobs based on the work and wages, rather than the cost of the company drug plan.

A prescription for equity: ensuring young Canadians’ health through National Pharmacare

OpinionBY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED

A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to choose jobs based on the work and wages, rather than the cost of the company drug plan.